Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Mar 23;20(12):2888–2894.e1. doi: 10.1016/j.cgh.2022.03.018

Table 2:

Average (SD) number of extra-intestinal Symptoms per participant at baseline and end of study

Baseline Mean (SD) End of Study Mean (SD) p value
DBM (N=30) 5.03 (3.30) 2.93 (3.06) <0.001
DBP (N=71) 4.93 (3.19) 3.38 (2.66) <0.001
TAU (N=72) 5.35 (3.29) 4.04 (3.11) <0.001

DBP = Double Blind Placebo; DPM = Double Blind Mint; TAU=Treatment as Usual